Company Profile

With minimal technology-enhanced solutions to enable clinicians to help patients with Lymphedema -- a permanent limb swelling disease affecting 4 million US residents people in the US - patients worry about their risk of developing lymphedema after they survive cancer. Clinicians are frustrated with lack of resources and solutions to help them care for patients and improve clinical outcomes whle hospitals and insurance companies want to provide effective efficient care and avoid the financial burdens of chronic disease management. LymphaTech’s mission is to provide technological solutions to this underserved population and to advance the standard of care